- Proposed REX Retail Offer
- Faron commences a share offering
- Initial positive data from Phase 2 of BEXMAB
- Issuance of warrants
- Founders named European Inventor Award finalists
- Replacement – Board Change
- Update on financial status
- Board Change
- Faron confirms plans under new leadership
- Appointment of Chief Financial Officer
More ▼
Key statistics
On Friday, Faron Pharmaceuticals Oy (FARN:LSE) closed at 96.00, 6.55% above its 52-week low of 90.10, set on Jun 04, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 98.00 |
---|---|
High | 97.00 |
Low | 96.00 |
Bid | 91.00 |
Offer | 101.00 |
Previous close | 96.00 |
Average volume | 146.32k |
---|---|
Shares outstanding | 72.01m |
Free float | 43.72m |
P/E (TTM) | -- |
Market cap | 133.23m GBP |
EPS (TTM) | -0.4038 GBP |
Data delayed at least 20 minutes, as of Jun 07 2024 17:08 BST.
More ▼